Avadel can seek to expand Lumryz’s label after court rulingnews2025-05-07T16:58:56+00:00May 7th, 2025|Endpoints News|
Drugmakers to push back on Trump plan for ‘most favored nation’ pricesnews2025-05-07T16:56:00+00:00May 7th, 2025|Endpoints News|
Judge hands win to FDA, Lilly in tirzepatide shortage casenews2025-05-07T16:37:46+00:00May 7th, 2025|Endpoints News|
Endpoints livestream: What Vinay Prasad means for CBER and FDAnews2025-05-07T11:00:47+00:00May 7th, 2025|Endpoints News|
Novo Nordisk Q1 earnings: Growth forecast trimmed as GLP-1 compounder ban yet to go livenews2025-05-07T10:52:09+00:00May 7th, 2025|Endpoints News|
Sarepta’s stock plummets after Prasad appointment, low Elevidys salesnews2025-05-07T01:28:08+00:00May 7th, 2025|Endpoints News|
States sue US over plan for reorganization of federal health agenciesnews2025-05-06T19:29:20+00:00May 6th, 2025|Endpoints News|
Plans to match US drug prices to those overseas gain steam in Washingtonnews2025-05-06T18:32:00+00:00May 6th, 2025|Endpoints News|
Trump, FDA zero in on foreign factories to give domestic sites an edge news2025-05-06T17:35:14+00:00May 6th, 2025|Endpoints News|
Europe pledges €500M to attract global science talentnews2025-05-06T16:57:04+00:00May 6th, 2025|Endpoints News|
